Related Articles
EGFR, but not COX‑2, protein in resected pancreatic ductal adenocarcinoma is associated with poor survival
Survival‑associated factors of first‑line EGFR‑tyrosine kinase inhibitor responders and non‑responders in lung adenocarcinoma patients with common EGFR mutations
Expression of insulin-like growth factor-II mRNA-binding protein-3 as a marker for predicting clinical outcome in patients with esophageal squamous cell carcinoma
Predictive value of tumor genetic alteration profiling for chemotherapy and EGFR‑TKI treatment in advanced NSCLC
Expression and clinical significance of the phosphatidylinositol 3‑kinase/protein kinase B signal transduction pathway in non‑small cell lung carcinoma